By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Sclerosing agents > Sodium tetradecyl sulfate > Sodium Tetradecyl Sulfate Dosage
Sclerosing agents
https://themeditary.com/dosage-information/sodium-tetradecyl-sulfate-dosage-8907.html

Sodium Tetradecyl Sulfate Dosage

Drug Detail:Sodium tetradecyl sulfate (Sodium tetradecyl sulfate [ soo-dee-um-tet-ra-des-il-sul-fate ])

Drug Class: Sclerosing agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Varicose Vein

Initial dose: 0.5 mL to 2 mL for each injection, with a preferred 1 mL maximum per injection and 10 mL maximum per treatment session. The dosage should be kept as small as possible.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Sodium tetradecyl sulfate should only be administered by a physician familiar with the diagnosis and treatment of conditions affecting the venous system and with the proper injection technique. Extravasation may result in severe local adverse reactions including necrosis. Extreme care in needle placement and use of the minimal effective volume at each injection site are recommended.

To avoid anaphylactic shock, a small (0.5 mL) dose of sodium tetradecyl sulfate should be injected into a varicosity and the patient observed for several hours. The appropriate treatments should be readily available should the patient experience an allergic reaction.

Deep venous patency must be determined prior to initiation of sodium tetradecyl sulfate treatment to avoid the development of deep vein thrombosis and pulmonary embolism. Venous sclerotherapy should not be initiated in patients showing significant valvular or deep venous incompetence. Patients should be evaluated following treatment to assess for the development of deep vein thrombosis, as embolism may occur as long as four weeks after injection. Adequate post-treatment compression may decrease the incidence of deep vein thrombosis.

The benefit-to-risk ratio should be considered in patients who are great surgical risks.

Safety and efficacy in pediatric patients have not been established.

Dialysis

Data not available

Other Comments

The strength of the solution required depends on the size and degree of the varicosity. In general, the 1% solution will be effective in the treatment of most varicosities. The 3% solution should be reserved for larger varicosities.

Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by